These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 20725711)

  • 1. Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease.
    Ren J; Pulakat L; Whaley-Connell A; Sowers JR
    J Mol Med (Berl); 2010 Oct; 88(10):993-1001. PubMed ID: 20725711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance.
    Cooper SA; Whaley-Connell A; Habibi J; Wei Y; Lastra G; Manrique C; Stas S; Sowers JR
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2009-23. PubMed ID: 17586614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of AMP-activated protein kinase on cardio-metabolic abnormalities in the development of diabetic cardiomyopathy: A molecular landscape.
    Haye A; Ansari MA; Rahman SO; Shamsi Y; Ahmed D; Sharma M
    Eur J Pharmacol; 2020 Dec; 888():173376. PubMed ID: 32810493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective mitochondrial biogenesis: a hallmark of the high cardiovascular risk in the metabolic syndrome?
    Nisoli E; Clementi E; Carruba MO; Moncada S
    Circ Res; 2007 Mar; 100(6):795-806. PubMed ID: 17395885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapies.
    Ilkun O; Boudina S
    Curr Pharm Des; 2013; 19(27):4806-17. PubMed ID: 23323621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved endogenous epoxyeicosatrienoic acid production mends heart function via increased PGC 1α-mitochondrial functions in metabolic syndrome.
    Liu L; Huang X; Gao J; Guo Y; Di Y; Sun S; Deng X; Cao J
    J Pharmacol Sci; 2018 Oct; 138(2):138-145. PubMed ID: 30342783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitoprotection attenuates myocardial vascular impairment in porcine metabolic syndrome.
    Yuan F; Hedayat AF; Ferguson CM; Lerman A; Lerman LO; Eirin A
    Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H669-H680. PubMed ID: 29196345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of mitochondrial biogenesis in metabolic syndrome.
    Rolo AP; Gomes AP; Palmeira CM
    Curr Drug Targets; 2011 Jun; 12(6):872-8. PubMed ID: 21269264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the Zucker obese rat.
    Zhou X; Ma L; Habibi J; Whaley-Connell A; Hayden MR; Tilmon RD; Brown AN; Kim JA; Demarco VG; Sowers JR
    Hypertension; 2010 Apr; 55(4):880-8. PubMed ID: 20176997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial abnormalities: a hub in metabolic syndrome-related cardiac dysfunction caused by oxidative stress.
    Li A; Zheng N; Ding X
    Heart Fail Rev; 2022 Jul; 27(4):1387-1394. PubMed ID: 33950478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial AMPK activation induces mitochondrial biogenesis and stress adaptation via eNOS-dependent mTORC1 signaling.
    Li C; Reif MM; Craige SM; Kant S; Keaney JF
    Nitric Oxide; 2016 May; 55-56():45-53. PubMed ID: 26989010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astaxanthin stimulates mitochondrial biogenesis in insulin resistant muscle via activation of AMPK pathway.
    Nishida Y; Nawaz A; Kado T; Takikawa A; Igarashi Y; Onogi Y; Wada T; Sasaoka T; Yamamoto S; Sasahara M; Imura J; Tokuyama K; Usui I; Nakagawa T; Fujisaka S; Kunimasa Y; Tobe K
    J Cachexia Sarcopenia Muscle; 2020 Feb; 11(1):241-258. PubMed ID: 32003547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen and mitochondria function in cardiorenal metabolic syndrome.
    Jia G; Aroor AR; Sowers JR
    Prog Mol Biol Transl Sci; 2014; 127():229-49. PubMed ID: 25149220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension.
    Sowers JR; Whaley-Connell A; Epstein M
    Ann Intern Med; 2009 Jun; 150(11):776-83. PubMed ID: 19487712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of mitochondrial dysfunction in insulin resistance.
    Kim JA; Wei Y; Sowers JR
    Circ Res; 2008 Feb; 102(4):401-14. PubMed ID: 18309108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased endothelial nitric oxide synthase expression and function contribute to impaired mitochondrial biogenesis and oxidative stress in fetal lambs with persistent pulmonary hypertension.
    Afolayan AJ; Eis A; Alexander M; Michalkiewicz T; Teng RJ; Lakshminrusimha S; Konduri GG
    Am J Physiol Lung Cell Mol Physiol; 2016 Jan; 310(1):L40-9. PubMed ID: 26519208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. eNOS, metabolic syndrome and cardiovascular disease.
    Huang PL
    Trends Endocrinol Metab; 2009 Aug; 20(6):295-302. PubMed ID: 19647446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates.
    Jobgen WS; Fried SK; Fu WJ; Meininger CJ; Wu G
    J Nutr Biochem; 2006 Sep; 17(9):571-88. PubMed ID: 16524713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between maternal and postnatal high fat diet leads to a greater risk of myocardial dysfunction in offspring via enhanced lipotoxicity, IRS-1 serine phosphorylation and mitochondrial defects.
    Turdi S; Ge W; Hu N; Bradley KM; Wang X; Ren J
    J Mol Cell Cardiol; 2013 Feb; 55():117-29. PubMed ID: 23266593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.